These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9762805)

  • 1. Sarcoidosis: immunopathogenetic concepts and their clinical application.
    Müller-Quernheim J
    Eur Respir J; 1998 Sep; 12(3):716-38. PubMed ID: 9762805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of sarcoidosis].
    Müller-Quernheim J
    Versicherungsmedizin; 1995 Dec; 47(6):216-21. PubMed ID: 8571499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung.
    Milburn HJ; Poulter LW; Dilmec A; Cochrane GM; Kemeny DM
    Clin Exp Immunol; 1997 Apr; 108(1):105-13. PubMed ID: 9097918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
    Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytokine network in sarcoidosis and its clinical relevance.
    Ziegenhagen MW; Müller-Quernheim J
    J Intern Med; 2003 Jan; 253(1):18-30. PubMed ID: 12588535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
    Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sarcoidosis: immunopathology and criteria of biological activity].
    Müller-Quernheim J; Ménard O
    Rev Mal Respir; 1995; 12(6):525-31. PubMed ID: 8677346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applied clinical immunology in sarcoidosis.
    Semenzato G; Bortoli M; Agostini C
    Curr Opin Pulm Med; 2002 Sep; 8(5):441-4. PubMed ID: 12172450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.
    Lawrence EC; Brousseau KP; Berger MB; Kurman CC; Marcon L; Nelson DL
    Am Rev Respir Dis; 1988 Apr; 137(4):759-64. PubMed ID: 3128148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous sarcoidosis therapy updated.
    Badgwell C; Rosen T
    J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYFRA 21-1, a cytokeratin subunit 19 fragment, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kanazawa H; Yoshikawa T; Yamada M; Shoji S; Fujii T; Kudoh S; Hirata K; Yoshikawa J
    Clin Sci (Lond); 1998 May; 94(5):531-5. PubMed ID: 9682677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticarbohydrate autoantibodies to sialidase-treated erythrocytes and thymocytes in serum from patients with pulmonary sarcoidosis.
    Pilatte Y; Tisserand EM; Greffard A; Bignon J; Lambré CR
    Am J Med; 1990 May; 88(5):486-92. PubMed ID: 2186624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T lymphocytes in sarcoidosis].
    Tazi A; Hance AJ
    Presse Med; 1999 Oct; 28(31):1723-8. PubMed ID: 10554616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of immune cells in sarcoidosis: immunopathogenic and clinical implications].
    Müller-Quernheim J
    Immun Infekt; 1995 Jun; 23(3):80-5. PubMed ID: 7615306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on sarcoidosis].
    Tazi A
    Rev Pneumol Clin; 2005 Jun; 61(3):203-10. PubMed ID: 16142194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology, rheumatic features, and therapy of sarcoidosis.
    Mathur A; Kremer JM
    Curr Opin Rheumatol; 1992 Feb; 4(1):76-80. PubMed ID: 1543666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expansions of T lymphocyte subpopulations in the lung and corticosteroid-induced changes in patients with active pulmonary sarcoidosis.
    Rossi GA; Sacco O; Cosulich E; Balbi B; Risso A; Ravazzoni C
    Ann N Y Acad Sci; 1986; 465():130-9. PubMed ID: 3488000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis.
    Moller DR; Forman JD; Liu MC; Noble PW; Greenlee BM; Vyas P; Holden DA; Forrester JM; Lazarus A; Wysocka M; Trinchieri G; Karp C
    J Immunol; 1996 Jun; 156(12):4952-60. PubMed ID: 8648147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of serum cytokine network in sarcoid patients: index of sarcoidosis relapse?
    Salmeri FM; Sofo V; Andò FG; Vastola MB; Crosca S; Bitto A; Gaeta M; Girbino G
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):53-61. PubMed ID: 12737281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.